
Part 4 of 4: Why better planning for surgical growth, operational performance, and patient safety requires sterile processing expertise early in the decision-making process.
In October 2011, more than 275 participants convened at the Food and Drug Administration (FDA) headquarters in Silver Spring, Md., for a multidisciplinary Medical Device Reprocessing Summit sponsored by the FDA in collaboration with the Association for the Advancement of Medical Instrumentation (AAMI).







